Senior Scientist, Downstream Process Development and Scale-up
Danaher Corporation
Summary
The Senior Scientist, Downstream Process Development and Scale-up is responsible for leading projects in Fast Trak Process Development Services (PDS) Downstream team. The person will provide technical and operational leadership to deliver high-quality process development, scale-up, technology transfer, training, and customer support activities. This role serves as a key technical leader and customer-facing subject matter expert supporting viral vectors, other biologics, and emerging therapeutic modalities.
Job description
What you will do
- Lead planning, execution, and delivery of downstream process development, scale-up, and technology transfer activities for viral vectors and other advanced therapy modalities.
- Perform independent work, analysis and troubleshooting. Document development work in concise reports and provide project updates in written and oral presentations.
- Serve as a technical subject matter expert (SME) during customer meetings, project reviews, technical investigations, risk assessments, and troubleshooting activities.
- Support proposal development, scope definition, technical reviews, customer presentations, and drive robust documentation practices including SOPs, study plans, batch records, investigations, technical reports, and technology transfer documentation.
- Partner closely with upstream, analytics, applications, automation, R&D, commercial, and PMO teams to ensure successful project execution and foster scientific collaborations within Fast Trak PD, cross-functional teams, and customers to drive efficient execution of internal and external KPIs.
Who you are
- Bachelor's degree or higher in chemical engineering, molecular biology, biochemistry, or a related discipline (MS or PhD preferred), with 5+ years of relevant industry experience leading and executing downstream process development and scale-up projects for biological molecules.
- Trusted technical advisor with extensive knowledge and hands-on experience of downstream unit operations across process development, scale-up, and technology transfer.
- Strong team player with excellent organizational, communication, and presentation skills.
- Willingness to participate in customer-site activities, on-site support, and technology transfer programs as needed.
Travel, Motor Vehicle Record & Physical/Environment Requirements
- Ability and willingness to work in laboratory and pilot-scale environments, including BSL-2 laboratories when required.
- Ability and willingness to travel domestically and internationally to support customer engagements, technology transfers, training, and conferences.
- Flexibility to support occasional off-hours activities associated with critical project milestones and schedules.
It would be a plus if you also possess previous experience in
- Large scale purification of monoclonal antibodies, fusion proteins and viral vectors.
Requirements
- Bachelor's degree or higher in chemical engineering, molecular biology, biochemistry, or a related discipline
- 5+ years of relevant industry experience leading and executing downstream process development and scale-up projects for biological molecules
- Extensive knowledge and hands-on experience of downstream unit operations across process development, scale-up, and technology transfer
- Strong organizational, communication, and presentation skills
- Willingness to participate in customer-site activities, on-site support, and technology transfer programs
- Ability and willingness to work in laboratory and pilot-scale environments, including BSL-2 laboratories
- Ability and willingness to travel domestically and internationally
- Flexibility to support occasional off-hours activities
Benefits
- Health care program
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.